IGC Pharma (IGC) Change in Inventory (2010 - 2025)

IGC Pharma (IGC) reported Change in Inventory of -$6000.0 for Q3 2025, up 45.45% quarter-over-quarter from -$11000.0 in Q2 2025.

IGC Pharma (IGC) Change in Inventory (2010 - 2025) Analysis & Trends

IGC Pharma (IGC) has 16 years of Change in Inventory data on file, last reported at -$6000.0 in Q3 2025.

Change in Inventory for Q3 2025 came in at -$6000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was -$167000.0 (up 83.68% YoY), and the FY2025 annual result was -$180000.0, up 82.14% from the prior year.
Change in Inventory grew to -$6000.0 in Q3 2025 per IGC's latest filing, from -$11000.0 in the prior quarter.
Over five years, Change in Inventory peaked at $322000.0 in Q1 2021 and troughed at -$1.9 million in Q1 2022.
A 5-year average of -$206111.1 and a median of -$8000.0 in 2023 frame the typical range for Change in Inventory.
On a YoY basis, Change in Inventory climbed as much as 3800.0% in 2022 and fell as far as 683.54% in 2022.
A 5-year view of Change in Inventory shows it stood at -$71000.0 in 2021, then jumped by 97.18% to -$2000.0 in 2022, then soared by 1250.0% to $23000.0 in 2023, then sank by 434.78% to -$77000.0 in 2024, then soared by 92.21% to -$6000.0 in 2025.
Business Quant data shows IGC's Change in Inventory at -$6000.0 in Q3 2025, -$11000.0 in Q2 2025, and -$73000.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change Inventory (Qtr)
1	Alterity Therapeutics	719,706.53 Bn	719,706.50 Bn	-	-
2	Belite Bio	55,800.00 Bn	55,800.00 Bn	-	-
3	Quantum Biopharma	18,182.30 Bn	18,182.29 Bn	-	51,468.00
4	Legend Biotech	3,154.00 Bn	3,153.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,844.30 Bn	1,844.29 Bn	-	-
6	Evaxion A	1,567.96 Bn	1,567.94 Bn	-	-
7	Psyence Biomedical	251.43 Bn	251.42 Bn	-	-
8	Vertex Pharmaceuticals	112.56 Bn	105.31 Bn	2.59 Bn	97.70 Mn
9	Abivax	94.37 Bn	94.37 Bn	-	-
10	IGC Pharma	29.33 Mn	29.07 Mn	-	-

Download Data